Infectious Diseases Half of COVID Survivors Experience Lingering Symptoms Six Months After Recovery by Global Biodefense Staff October 13, 2021
Infectious Diseases Vaccination Significantly Reduces Risk of Developing Long COVID by Global Biodefense Staff October 3, 2021
Infectious Diseases Artificial Intelligence Triage Tool Screens for COVID 26% Faster Than Traditional Diagnostics by Global Biodefense Staff September 16, 2021
Infectious Diseases Biomarkers Identified to Predict Severe Dengue by Global Biodefense Staff June 22, 2021
Infectious Diseases COVID-19: Men Create More Antibodies After Asymptomatic Infection, and Keep Them Longer by Global Biodefense Staff April 7, 2021
Infectious Diseases Ebola Might Be a Chronic Infection – But Here’s Why We Shouldn’t Panic by Global Biodefense Staff March 29, 2021
Infectious Diseases Study Could Explain Tuberculosis Bacteria Paradox by Global Biodefense Staff March 19, 2021
Infectious Diseases What Happens When a Person Is Simultaneously Infected with Two Different SARS-CoV-2 Variants? by Global Biodefense Staff March 17, 2021
Infectious Diseases NIH Effort Seeks to Understand MIS-C, Range of SARS-CoV-2 Effects on Children by Global Biodefense Staff March 16, 2021
Infectious Diseases Naval Medical Research Center Continues COVID-19 Recovery Study by Global Biodefense Staff March 11, 2021
Infectious Diseases Trial of Novel MIS-C Therapy Underway at Medical University of South Carolina by Global Biodefense Staff March 10, 2021
Infectious Diseases T Cell Activation in Children with MIS-C More Similar to Adults with Severe COIVD-19 by Global Biodefense Staff March 2, 2021
Infectious Diseases How Do We Know the COVID Vaccine Won’t Have Long-Term Side-Effects? by Global Biodefense Staff February 23, 2021
Infectious Diseases Naval Medical Center San Diego Administers Hospital’s First mAb Treatment to COVID-19 Patient by Global Biodefense Staff January 30, 2021
Infectious Diseases NSAIDs Might Exacerbate or Suppress COVID-19 Depending on Timing by Global Biodefense Staff January 26, 2021
Biodetection ‘Test to Release’ Strategy Could Potentially Cut COVID-19 Quarantine Time in Half by Global Biodefense Staff January 26, 2021
Infectious Diseases At the Top of the COVID-19 Research Agenda: Asymptomatic Spread and Long-Term Health Impacts by Global Biodefense Staff January 26, 2021
Infectious Diseases NeuroCOVID: New Database to Track Neurological Symptoms Associated with SARS-CoV-2 Infection by Global Biodefense Staff January 26, 2021
Infectious Diseases Researchers Determine How SARS-CoV-2 Hijacks and Rapidly Damages Human Lung Cells by Global Biodefense Staff December 2, 2020
Infectious Diseases Dublin-Boston Scoring System Helps Predict Which COVID-19 Patients Will Develop Severe Infection by Global Biodefense Staff October 14, 2020
